Arthur G. Palmer and Oliver Hobert of the Department of Biochemistry & Molecular Biophysics were selected in recognition of their distinguished and continuing achievements in research.
A study co-led by Columbia scientists suggests a nutrient transporter located at the blood-brain barrier could be commandeered to sneak therapeutic drugs into the brain.
Columbia researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
Warning letters from Medicare sent to high prescribers reduced prescriptions of risky antipsychotics for elderly people with dementia without negatively affecting patient health.
People with a history of cognitively stimulating occupations during their 30s, 40s, 50s, and 60s had a lower risk of mild cognitive impairment and dementia after age 70.
Mice lacking an olfactory system have had their sense of smell restored with rat neurons, the first time scientists have successfully integrated the sensory apparatus of one species into another.
Jonathan Dworkin, PhD, professor of microbiology & immunology at the Vagelos College of Physicians and Surgeons, has been named a fellow of the American Association for the Advancement of Science.
New details about the way this important molecule takes on tasks beyond sensing calcium could spur the develop of new drugs for breast cancer and other diseases.
BeatProfiler, a new research tool invented by Columbia bioengineers with the help of AI, speeds and simplifies the analysis of engineered heart tissue in the laboratory.
Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.